Aidoc, a Tel, Aviv, Israel- based leading provider of healthcare AI solutions, has announced that it raised a $110 million in Series D round investment, bringing its total funding to $250 million.
The round was co-led by global growth investors TCV and Alpha Intelligence Capital (AIC), with participation from AIC's co-investor CDIB Capital, which will power the continued expansion of the Aidoc AI Care Platform.
Company: Aidoc Medical Ltd.
Round: Series B
Funding Month: June 2022
Lead Investors: global growth investors TCV and Alpha Intelligence Capital (AIC)
Additional Investors: AIC's co-investor CDIB Capital
Company Website: https://www.aidoc.com/
Software Category: AI Care Platform
About the Company: Aidoc (aidoc.com) is the leading provider of artificial intelligence healthcare solutions that empower physicians to expedite patient treatment and enhance operational capabilities. Aidoc's AI Care Platform—the first of its kind—offers health systems a singular platform solution that works with physicians to manage the entire patient lifecycle—from diagnostic aid to consultation to suggested treatment paths to patient follow-up tools. In clinical studies, the Aidoc AI has proven to reduce the turnaround time, shorten the patient length of stay and improve patient outcomes.